In a letter to Wisconsin U.S. Senator Tammy Baldwin, WMC and other organizations, urged Congress to pass a clean Prescription Drug User Fee Act (PDUFA VII) to continue its crucial support of the Food and Drug Administration’s objectives.
PDUFA strengthens the FDA’s ability to review and approve new medicines and treatments. Since it was originally passed, PDUFA has helped cut the time it takes a new medicine to reach approval from more than two years to just 10 months. Streamlining the approval process means new treatments get to patients sooner, improving their health outcomes and quality of life. Additionally, PDUFA VII includes commitments that support innovation and patient centered medicine, by advancing patient perspectives and enhancing scientific expertise within the review process.